OT
The startup develops cell-related therapeutics utilizing induced pluripotent stem cells through cardiomyocyte differentiation and myocardial purification methods with small-molecule compounds. This research enables pre-clinical validation for improved regenerative medicine treatments and cell transplantation procedures.
Updated 3 months ago
Funding
$90.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops cell-related therapeutics utilizing induced pluripotent stem cells through cardiomyocyte differentiation and myocardial purification methods with small-molecule compounds. This research enables pre-clinical validation for improved regenerative medicine treatments and cell transplantation procedures.